BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 9987742)

  • 1. Well-differentiated endometrial adenocarcinoma in an infertility patient with later conception. A case report.
    Kowalczyk CL; Malone J; Peterson EP; Jacques SM; Leach RE
    J Reprod Med; 1999 Jan; 44(1):57-60. PubMed ID: 9987742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occult myometrial recurrence after progesterone therapy to preserve fertility in a young patient with endometrial cancer.
    Hurst SA; Hartzfeld KM; Del Priore G
    Fertil Steril; 2008 Mar; 89(3):724.e1-3. PubMed ID: 17570366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Outcome analysis of conservative treatment of well-differentiated endometrial adenocarcinoma and severe atypical hyperplasia in young women].
    Yu M; Shen K; Yang JX; Huang HF; Wu M; Pan LY; Lang JH; Lian LJ
    Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):242-5. PubMed ID: 16759458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A successful live twin birth by in vitro fertilization after conservative treatment of recurrent endometrial cancer.
    Wu HM; Lai CH; Huang HY; Wang HS; Soong YK
    Chang Gung Med J; 2008; 31(1):102-6. PubMed ID: 18419059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of conservative therapy for young women with early endometrial adenocarcinoma.
    Mao Y; Wan X; Chen Y; Lv W; Xie X
    Fertil Steril; 2010 Jan; 93(1):283-5. PubMed ID: 19962142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian metastasis in a nulliparous woman with endometrial adenocarcinoma failing conservative hormonal treatment.
    Huang SY; Jung SM; Ng KK; Chang YC; Lai CH
    Gynecol Oncol; 2005 May; 97(2):652-5. PubMed ID: 15863173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of fertility-preserving treatment in young women with endometrial carcinomas.
    Niwa K; Tagami K; Lian Z; Onogi K; Mori H; Tamaya T
    BJOG; 2005 Mar; 112(3):317-20. PubMed ID: 15713146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of in vitro fertilization treatment in infertile women conservatively treated for endometrial adenocarcinoma.
    Elizur SE; Beiner ME; Korach J; Weiser A; Ben-Baruch G; Dor J
    Fertil Steril; 2007 Dec; 88(6):1562-7. PubMed ID: 17412340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Endometrial adenocarcinoma in women 40 years old or younger by treatment with progestins: report of 6 cases and review of the literatures].
    Wang HY; Shen L; Sun Z
    Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):237-41. PubMed ID: 16759457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pregnancy outcome in patients with stage 1a endometrial adenocarcinoma, who conservatively treated with megestrol acetate.
    Shirali E; Yarandi F; Eftekhar Z; Shojaei H; Khazaeipour Z
    Arch Gynecol Obstet; 2012 Mar; 285(3):791-5. PubMed ID: 21805142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fertility-sparing therapy for young women with endometrial cancer.
    Frumovitz M; Gershenson DM
    Expert Rev Anticancer Ther; 2006 Jan; 6(1):27-32. PubMed ID: 16375641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fertility-preserving treatment in young women with well-differentiated endometrial carcinoma and severe atypical hyperplasia of endometrium.
    Yu M; Yang JX; Wu M; Lang JH; Huo Z; Shen K
    Fertil Steril; 2009 Dec; 92(6):2122-4. PubMed ID: 19591991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stage IV endometrial cancer after failed conservative management: a case report.
    Kothari R; Seamon L; Cohn D; Fowler J; O'Malley DM
    Gynecol Oncol; 2008 Dec; 111(3):579-82. PubMed ID: 18395778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reevaluating the safety of fertility-sparing hormonal therapy for early endometrial cancer.
    Yang YC; Wu CC; Chen CP; Chang CL; Wang KL
    Gynecol Oncol; 2005 Nov; 99(2):287-93. PubMed ID: 16051341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathologic characteristics and treatment features of women with the incidental diagnosis of endometrial adenocarcinoma during infertility follow-up in Ankara, Turkey.
    Gungor T; Cetinkaya N; Yalcin H; Zergeroglu S; Erkaya S
    Taiwan J Obstet Gynecol; 2016 Jun; 55(3):309-13. PubMed ID: 27343306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression of conservatively treated endometrial complex atypical hyperplasia in a young woman: a case report.
    Corrado G; Baiocco E; Carosi M; Vizza E
    Fertil Steril; 2008 Nov; 90(5):2006.e5-8. PubMed ID: 18692828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endometrial carcinoma remaining after term pregnancy following conservative treatment with medroxyprogesterone acetate.
    Mitsushita J; Toki T; Kato K; Fujii S; Konishi I
    Gynecol Oncol; 2000 Oct; 79(1):129-32. PubMed ID: 11006045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pregnant rate and pregnancy-relating factors of patients with early endometrial carcinoma and severe atypical hyperplasia of endometrium after fertility-preserving treatment by progestin].
    Cao DY; Yu M; Yang JX; Shen K; Huang HF; Cheng NH; Sun ZY; Deng CY; Yu Q; He FF
    Zhonghua Fu Chan Ke Za Zhi; 2013 Jul; 48(7):519-22. PubMed ID: 24284224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sparing fertility in young patients with endometrial cancer.
    Chiva L; Lapuente F; González-Cortijo L; Carballo N; García JF; Rojo A; Gonzalez-Martín A
    Gynecol Oncol; 2008 Nov; 111(2 Suppl):S101-4. PubMed ID: 18804267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review.
    Ramirez PT; Frumovitz M; Bodurka DC; Sun CC; Levenback C
    Gynecol Oncol; 2004 Oct; 95(1):133-8. PubMed ID: 15385122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.